2016
DOI: 10.1212/wnl.0000000000003258
|View full text |Cite
|
Sign up to set email alerts
|

HIV-associated motor neuron disease

Abstract: Objective: To determine whether there is activation of human endogenous retrovirus K (HERV-K) in amyotrophic lateral sclerosis in HIV infection and whether it might respond to treatment with antiretroviral drugs. Methods:In this case series, we present 5 patients with HIV infection who subsequently developed motor neuron disease involving both upper and lower motor neurons. We monitored HERV-K levels in plasma of 4 of these patients.Results: Three patients who received antiretroviral therapy had reversal of sy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
39
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 69 publications
(39 citation statements)
references
References 30 publications
0
39
0
Order By: Relevance
“…Antiretroviral therapy can reverse the symptoms of this ALS-like syndrome in HIV-infected individuals ( Moulignier et al, 2001 ; von Giesen et al, 2002 ), suggesting that HIV replication in the CNS can drive a pathology which symptomatically resembles ALS. Indeed, recent attempts treat HIV-associated motor neuron disease with antiretroviral therapy showed promise, with reversal of recent onset symptoms or a protracted course of the illness following treatment ( Bowen et al, 2016 ). In these patients, the clinical improvement paralleled a decrease in HERV-K viral load in plasma ( Bowen et al, 2016 ).…”
Section: Future Directionsmentioning
confidence: 99%
See 1 more Smart Citation
“…Antiretroviral therapy can reverse the symptoms of this ALS-like syndrome in HIV-infected individuals ( Moulignier et al, 2001 ; von Giesen et al, 2002 ), suggesting that HIV replication in the CNS can drive a pathology which symptomatically resembles ALS. Indeed, recent attempts treat HIV-associated motor neuron disease with antiretroviral therapy showed promise, with reversal of recent onset symptoms or a protracted course of the illness following treatment ( Bowen et al, 2016 ). In these patients, the clinical improvement paralleled a decrease in HERV-K viral load in plasma ( Bowen et al, 2016 ).…”
Section: Future Directionsmentioning
confidence: 99%
“…Indeed, recent attempts treat HIV-associated motor neuron disease with antiretroviral therapy showed promise, with reversal of recent onset symptoms or a protracted course of the illness following treatment ( Bowen et al, 2016 ). In these patients, the clinical improvement paralleled a decrease in HERV-K viral load in plasma ( Bowen et al, 2016 ). Future research into HIV-associated motor deficits in pediatric and adult populations should consider the potential of HERV-K in driving motor impairment.…”
Section: Future Directionsmentioning
confidence: 99%
“…The positive selection of persistent ERVs in the genome may have resulted from increasing the probability of survival to reproductive age [via adaptive effects on placentation (Simpson et al, 1996 ); and immune (Hurst and Magiorkinis, 2015 ) and brain development (Mortelmans et al, 2016 )]. The phenotypic effects of ERVs on the post-reproductive adult, however, remain unclear and are of growing interest (Li et al, 2015 ; Bowen et al, 2016 ; Sekar et al, 2016 ).…”
Section: Introductionmentioning
confidence: 99%
“…HERV-K was recently shown to be activated in a subpopulation of patients with sporadic amyotrophic lateral sclerosis (ALS) and the expression of HERV-K or its env protein in human neurons caused retraction and beading of neurites. Excitingly, expression of HERV-K is regulated by TAR (trans-activation responsive) DNA binding protein 43, the main aggregating protein in sporadic ALS, which binds to the long terminal repeat region of the virus [50,56,57]. Thus, viral infections might represent environmental risk factors of and possible contributors to ALS pathogenesis.…”
Section: Discussionmentioning
confidence: 99%